Global Neurological Biomarkers Market Size, Share & Industry Trends Analysis Report By Type (Proteomic, Genomic, Metabolomic), By Application (Alzheimer's Disease, Parkinson’s Disease and Multiple Sclerosis), By Regional Outlook and Forecast, 2022 - 2028
Published Date : 31-Oct-2022 | Pages: 163 | Formats: PDF |
COVID-19 Impact on the Neurological Biomarkers Market
Market Overview
The Global Neurological Biomarkers Market size is expected to reach $12.9 billion by 2028, rising at a market growth of 14.2% CAGR during the forecast period.
The term "biomarker," a portmanteau of "biological marker," refers to a large subclass of medical signs, or objective indicators of health status seen from the outside of the patient, which can be quantified precisely and consistently. Medical symptoms, on the other hand, are only those markers of health or disease that patients themselves may perceive. The literature contains several more detailed definitions of biomarkers, and they have a lot in common.
A biomarker is "a characteristic that is measured and evaluated objectively as an indicator of normal biochemical functions, pathogenic processes, or pharmacologic responses to a therapeutic intervention," according to the National Institutes of Health Biomarkers Definitions Working Group definition from 1998.
The World Health Organization (WHO), in collaboration with the United Nations and the International Labor Organization, established the International Program on Chemical Safety, which defines a biomarker as "any substance, structure, or procedure that can be evaluated in the body or its product lines and influence or predict the incidence of outcome or disease.
A definition that goes even further considers not only the occurrence and course of a disease, but also its treatment, interventions, and even inadvertent environmental exposure to substances like toxins or nutrients. Before the invention of better technology, it was difficult for researchers to monitor brain health by analyzing molecules since there were so few biomarkers for neurological illnesses. This entails less invasive testing, quicker medication development, earlier diagnosis, and hopefully more efficient therapies.
COVID-19 Impact Analysis
Almost every business has been impacted by the unmatched worldwide public health emergency known as COVID-19, and the long-term impacts are expected to influence industry growth throughout the course of the forecast period. According to research by Diaceutics PLC (UK) on the diagnosis and biomarker testing rates for various cancer types, the number of newly diagnosed patients with metastatic non-small cell lung cancer decreased between February 2020 and March 2020. The rates of KRAS, BRAF, and EGFR testing, which are important indicators supporting the optimal choice of precision medicine medicines that benefit particular patients, were also significantly influenced by this abrupt decline in just one month.
Market Growth Factors
Companion Diagnostics Are Becoming More Important
In the practice of medicine, companion diagnostics and biomarkers are becoming more and more important, which has enhanced disease-specific diagnosis, therapy, and monitoring. It can be used to identify patients who will likely respond well to specific treatments or drugs. These diagnostics frequently go hand in hand with certain medicine.
The Growing Concept of Individual Medicine
In customized medicine, biomarkers are crucial because they can be used for diagnosis, prognosis, and choosing specific treatments. Personalized medicine has grown in popularity over time as a result of the different drawbacks of conventional methods for diagnosis and treatment. Numerous medical specialties from cancer to immunological disorders are moving toward individualized patient care based on their genetic profiles and phenotypic traits.
Marketing Restraining Factor:
High Startup Costs and Protracted Biomarker Development Cycles
Due to the variability in how well they perform in illness detection, evaluating biomarkers is a time-consuming process. As a result, the validation procedure grows expensive and time-consuming. The process and timetable for developing and validating biomarkers are therefore comparable across biomarker categories, with a few exceptions, because different categories of biomarkers frequently share common development and validation process phases.
Type Outlook
Based on the Type, the Neurological Biomarkers Market is segmented into Genomic, Proteomic, Metabolomic, and Others. The genomic segment acquired a significant revenue share in the neurological biomarkers market in 2021. Increased prevalence of neurological disorders, an increase in the estimated incidence of ischemic stroke, elevated demand for minimally procedures, technological advancements in clinical laboratory tests and rising public awareness of genomic biomarker-based personalized medicines are all contributing factors to the expansion of the genomic biomarkers market.
Application Outlook
On the basis of Application, the Neurological Biomarkers Market is divided into Parkinson's Disease, Alzheimer's Disease, and Multiple Sclerosis. The Alzheimer’s disease segment procured the largest revenue share in the neurological biomarkers market in 2021. due to an increase in clinical trials, research, and drug development as well as an increase in the prevalence of Alzheimer's disease. Drug development for Alzheimer's disease (AD) heavily relies on biomarkers.
| Report Attribute | Details |
|---|---|
| Market size value in 2021 | USD 5.2 Billion |
| Market size forecast in 2028 | USD 12.9 Billion |
| Base Year | 2021 |
| Historical Period | 2018 to 2020 |
| Forecast Period | 2022 to 2028 |
| Revenue Growth Rate | CAGR of 14.2% from 2022 to 2028 |
| Number of Pages | 163 |
| Number of Tables | 270 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling |
| Segments covered | Type, Application, Region |
| Country scope | US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Australia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria |
| Growth Drivers |
|
| Restraints |
|
Regional Outlook
Region-wise, the Neurological Biomarkers Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment garnered the highest revenue share in the neurological biomarkers market in 2021. The increase in American studies suggests a decrease in the age-specific risk of Alzheimer's disease and other forms of dementia in the United States and other high-income western nations over the previous 25 years.
Free Valuable Insights: Global Neurological Biomarkers Market size to reach USD 12.9 Billion by 2028
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. HOFFMANN-LA ROCHE LTD., Bio-Rad Laboratories, Inc., Merck Group, PERKINELMER INC., Shimadzu corporation, Thermo Fisher Scientific, Inc., Quanterix Corporation, Neuro-Bio Ltd., BioMérieux S.A. and Myriad Genetics, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Proteomic
- Genomic
- Metabolomic
- Others
By Application
- Alzheimer's Disease
- Parkinson’s Disease
- Multiple Sclerosis
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Australia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- F.HOFFMANN-LA ROCHE LTD.
- Bio-Rad Laboratories, Inc.
- Merck Group
- PERKINELMER INC.
- Shimadzu corporation
- Thermo Fisher Scientific, Inc.
- Quanterix Corporation
- Neuro-Bio Ltd.
- BioMérieux S.A.
- Myriad Genetics, Inc.
Table of contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Neurological Biomarkers Market, by Type
1.4.2 Global Neurological Biomarkers Market, by Application
1.4.3 Global Neurological Biomarkers Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Neurological Biomarkers Market by Type
3.1 Global Proteomic Market by Region
3.2 Global Genomic Market by Region
3.3 Global Metabolomic Market by Region
3.4 Global Others Market by Region
Chapter 4. Global Neurological Biomarkers Market by Application
4.1 Global Alzheimer's Disease Market by Region
4.2 Global Parkinson’s Disease Market by Region
4.3 Global Multiple Sclerosis Market by Region
Chapter 5. Global Neurological Biomarkers Market by Region
5.1 North America Neurological Biomarkers Market
5.1.1 North America Neurological Biomarkers Market by Type
5.1.1.1 North America Proteomic Market by Country
5.1.1.2 North America Genomic Market by Country
5.1.1.3 North America Metabolomic Market by Country
5.1.1.4 North America Others Market by Country
5.1.2 North America Neurological Biomarkers Market by Application
5.1.2.1 North America Alzheimer's Disease Market by Country
5.1.2.2 North America Parkinson’s Disease Market by Country
5.1.2.3 North America Multiple Sclerosis Market by Country
5.1.3 North America Neurological Biomarkers Market by Country
5.1.3.1 US Neurological Biomarkers Market
5.1.3.1.1 US Neurological Biomarkers Market by Type
5.1.3.1.2 US Neurological Biomarkers Market by Application
5.1.3.2 Canada Neurological Biomarkers Market
5.1.3.2.1 Canada Neurological Biomarkers Market by Type
5.1.3.2.2 Canada Neurological Biomarkers Market by Application
5.1.3.3 Mexico Neurological Biomarkers Market
5.1.3.3.1 Mexico Neurological Biomarkers Market by Type
5.1.3.3.2 Mexico Neurological Biomarkers Market by Application
5.1.3.4 Rest of North America Neurological Biomarkers Market
5.1.3.4.1 Rest of North America Neurological Biomarkers Market by Type
5.1.3.4.2 Rest of North America Neurological Biomarkers Market by Application
5.2 Europe Neurological Biomarkers Market
5.2.1 Europe Neurological Biomarkers Market by Type
5.2.1.1 Europe Proteomic Market by Country
5.2.1.2 Europe Genomic Market by Country
5.2.1.3 Europe Metabolomic Market by Country
5.2.1.4 Europe Others Market by Country
5.2.2 Europe Neurological Biomarkers Market by Application
5.2.2.1 Europe Alzheimer's Disease Market by Country
5.2.2.2 Europe Parkinson’s Disease Market by Country
5.2.2.3 Europe Multiple Sclerosis Market by Country
5.2.3 Europe Neurological Biomarkers Market by Country
5.2.3.1 Germany Neurological Biomarkers Market
5.2.3.1.1 Germany Neurological Biomarkers Market by Type
5.2.3.1.2 Germany Neurological Biomarkers Market by Application
5.2.3.2 UK Neurological Biomarkers Market
5.2.3.2.1 UK Neurological Biomarkers Market by Type
5.2.3.2.2 UK Neurological Biomarkers Market by Application
5.2.3.3 France Neurological Biomarkers Market
5.2.3.3.1 France Neurological Biomarkers Market by Type
5.2.3.3.2 France Neurological Biomarkers Market by Application
5.2.3.4 Russia Neurological Biomarkers Market
5.2.3.4.1 Russia Neurological Biomarkers Market by Type
5.2.3.4.2 Russia Neurological Biomarkers Market by Application
5.2.3.5 Spain Neurological Biomarkers Market
5.2.3.5.1 Spain Neurological Biomarkers Market by Type
5.2.3.5.2 Spain Neurological Biomarkers Market by Application
5.2.3.6 Italy Neurological Biomarkers Market
5.2.3.6.1 Italy Neurological Biomarkers Market by Type
5.2.3.6.2 Italy Neurological Biomarkers Market by Application
5.2.3.7 Rest of Europe Neurological Biomarkers Market
5.2.3.7.1 Rest of Europe Neurological Biomarkers Market by Type
5.2.3.7.2 Rest of Europe Neurological Biomarkers Market by Application
5.3 Asia Pacific Neurological Biomarkers Market
5.3.1 Asia Pacific Neurological Biomarkers Market by Type
5.3.1.1 Asia Pacific Proteomic Market by Country
5.3.1.2 Asia Pacific Genomic Market by Country
5.3.1.3 Asia Pacific Metabolomic Market by Country
5.3.1.4 Asia Pacific Others Market by Country
5.3.2 Asia Pacific Neurological Biomarkers Market by Application
5.3.2.1 Asia Pacific Alzheimer's Disease Market by Country
5.3.2.2 Asia Pacific Parkinson’s Disease Market by Country
5.3.2.3 Asia Pacific Multiple Sclerosis Market by Country
5.3.3 Asia Pacific Neurological Biomarkers Market by Country
5.3.3.1 China Neurological Biomarkers Market
5.3.3.1.1 China Neurological Biomarkers Market by Type
5.3.3.1.2 China Neurological Biomarkers Market by Application
5.3.3.2 Japan Neurological Biomarkers Market
5.3.3.2.1 Japan Neurological Biomarkers Market by Type
5.3.3.2.2 Japan Neurological Biomarkers Market by Application
5.3.3.3 India Neurological Biomarkers Market
5.3.3.3.1 India Neurological Biomarkers Market by Type
5.3.3.3.2 India Neurological Biomarkers Market by Application
5.3.3.4 Australia Neurological Biomarkers Market
5.3.3.4.1 Australia Neurological Biomarkers Market by Type
5.3.3.4.2 Australia Neurological Biomarkers Market by Application
5.3.3.5 South Korea Neurological Biomarkers Market
5.3.3.5.1 South Korea Neurological Biomarkers Market by Type
5.3.3.5.2 South Korea Neurological Biomarkers Market by Application
5.3.3.6 Singapore Neurological Biomarkers Market
5.3.3.6.1 Singapore Neurological Biomarkers Market by Type
5.3.3.6.2 Singapore Neurological Biomarkers Market by Application
5.3.3.7 Rest of Asia Pacific Neurological Biomarkers Market
5.3.3.7.1 Rest of Asia Pacific Neurological Biomarkers Market by Type
5.3.3.7.2 Rest of Asia Pacific Neurological Biomarkers Market by Application
5.4 LAMEA Neurological Biomarkers Market
5.4.1 LAMEA Neurological Biomarkers Market by Type
5.4.1.1 LAMEA Proteomic Market by Country
5.4.1.2 LAMEA Genomic Market by Country
5.4.1.3 LAMEA Metabolomic Market by Country
5.4.1.4 LAMEA Others Market by Country
5.4.2 LAMEA Neurological Biomarkers Market by Application
5.4.2.1 LAMEA Alzheimer's Disease Market by Country
5.4.2.2 LAMEA Parkinson’s Disease Market by Country
5.4.2.3 LAMEA Multiple Sclerosis Market by Country
5.4.3 LAMEA Neurological Biomarkers Market by Country
5.4.3.1 Brazil Neurological Biomarkers Market
5.4.3.1.1 Brazil Neurological Biomarkers Market by Type
5.4.3.1.2 Brazil Neurological Biomarkers Market by Application
5.4.3.2 Argentina Neurological Biomarkers Market
5.4.3.2.1 Argentina Neurological Biomarkers Market by Type
5.4.3.2.2 Argentina Neurological Biomarkers Market by Application
5.4.3.3 UAE Neurological Biomarkers Market
5.4.3.3.1 UAE Neurological Biomarkers Market by Type
5.4.3.3.2 UAE Neurological Biomarkers Market by Application
5.4.3.4 Saudi Arabia Neurological Biomarkers Market
5.4.3.4.1 Saudi Arabia Neurological Biomarkers Market by Type
5.4.3.4.2 Saudi Arabia Neurological Biomarkers Market by Application
5.4.3.5 South Africa Neurological Biomarkers Market
5.4.3.5.1 South Africa Neurological Biomarkers Market by Type
5.4.3.5.2 South Africa Neurological Biomarkers Market by Application
5.4.3.6 Nigeria Neurological Biomarkers Market
5.4.3.6.1 Nigeria Neurological Biomarkers Market by Type
5.4.3.6.2 Nigeria Neurological Biomarkers Market by Application
5.4.3.7 Rest of LAMEA Neurological Biomarkers Market
5.4.3.7.1 Rest of LAMEA Neurological Biomarkers Market by Type
5.4.3.7.2 Rest of LAMEA Neurological Biomarkers Market by Application
Chapter 6. Company Profiles
6.1 F. Hoffmann-La Roche Ltd.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Bio-Rad laboratories, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.3 Merck Group
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.4 PerkinElmer, Inc.
6.4.1 Company Overview
6.4.1 Financial Analysis
6.4.2 Segmental and Regional Analysis
6.4.3 Research & Development Expense
6.5 Shimadzu Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.6 Thermo Fisher Scientific, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 BioMérieux S.A.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expenses
6.8 Myriad Genetics, Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental Analysis
6.8.4 Research & Development Expenses
6.9 Quanterix Corporation
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expenses
6.9.5 Recent strategies and developments:
6.9.5.1 Partnerships, Collaborations, and Agreements:
6.10. Neuro-Bio Ltd.
6.10.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Neurological Biomarkers Market, by Type
1.4.2 Global Neurological Biomarkers Market, by Application
1.4.3 Global Neurological Biomarkers Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Neurological Biomarkers Market by Type
3.1 Global Proteomic Market by Region
3.2 Global Genomic Market by Region
3.3 Global Metabolomic Market by Region
3.4 Global Others Market by Region
Chapter 4. Global Neurological Biomarkers Market by Application
4.1 Global Alzheimer's Disease Market by Region
4.2 Global Parkinson’s Disease Market by Region
4.3 Global Multiple Sclerosis Market by Region
Chapter 5. Global Neurological Biomarkers Market by Region
5.1 North America Neurological Biomarkers Market
5.1.1 North America Neurological Biomarkers Market by Type
5.1.1.1 North America Proteomic Market by Country
5.1.1.2 North America Genomic Market by Country
5.1.1.3 North America Metabolomic Market by Country
5.1.1.4 North America Others Market by Country
5.1.2 North America Neurological Biomarkers Market by Application
5.1.2.1 North America Alzheimer's Disease Market by Country
5.1.2.2 North America Parkinson’s Disease Market by Country
5.1.2.3 North America Multiple Sclerosis Market by Country
5.1.3 North America Neurological Biomarkers Market by Country
5.1.3.1 US Neurological Biomarkers Market
5.1.3.1.1 US Neurological Biomarkers Market by Type
5.1.3.1.2 US Neurological Biomarkers Market by Application
5.1.3.2 Canada Neurological Biomarkers Market
5.1.3.2.1 Canada Neurological Biomarkers Market by Type
5.1.3.2.2 Canada Neurological Biomarkers Market by Application
5.1.3.3 Mexico Neurological Biomarkers Market
5.1.3.3.1 Mexico Neurological Biomarkers Market by Type
5.1.3.3.2 Mexico Neurological Biomarkers Market by Application
5.1.3.4 Rest of North America Neurological Biomarkers Market
5.1.3.4.1 Rest of North America Neurological Biomarkers Market by Type
5.1.3.4.2 Rest of North America Neurological Biomarkers Market by Application
5.2 Europe Neurological Biomarkers Market
5.2.1 Europe Neurological Biomarkers Market by Type
5.2.1.1 Europe Proteomic Market by Country
5.2.1.2 Europe Genomic Market by Country
5.2.1.3 Europe Metabolomic Market by Country
5.2.1.4 Europe Others Market by Country
5.2.2 Europe Neurological Biomarkers Market by Application
5.2.2.1 Europe Alzheimer's Disease Market by Country
5.2.2.2 Europe Parkinson’s Disease Market by Country
5.2.2.3 Europe Multiple Sclerosis Market by Country
5.2.3 Europe Neurological Biomarkers Market by Country
5.2.3.1 Germany Neurological Biomarkers Market
5.2.3.1.1 Germany Neurological Biomarkers Market by Type
5.2.3.1.2 Germany Neurological Biomarkers Market by Application
5.2.3.2 UK Neurological Biomarkers Market
5.2.3.2.1 UK Neurological Biomarkers Market by Type
5.2.3.2.2 UK Neurological Biomarkers Market by Application
5.2.3.3 France Neurological Biomarkers Market
5.2.3.3.1 France Neurological Biomarkers Market by Type
5.2.3.3.2 France Neurological Biomarkers Market by Application
5.2.3.4 Russia Neurological Biomarkers Market
5.2.3.4.1 Russia Neurological Biomarkers Market by Type
5.2.3.4.2 Russia Neurological Biomarkers Market by Application
5.2.3.5 Spain Neurological Biomarkers Market
5.2.3.5.1 Spain Neurological Biomarkers Market by Type
5.2.3.5.2 Spain Neurological Biomarkers Market by Application
5.2.3.6 Italy Neurological Biomarkers Market
5.2.3.6.1 Italy Neurological Biomarkers Market by Type
5.2.3.6.2 Italy Neurological Biomarkers Market by Application
5.2.3.7 Rest of Europe Neurological Biomarkers Market
5.2.3.7.1 Rest of Europe Neurological Biomarkers Market by Type
5.2.3.7.2 Rest of Europe Neurological Biomarkers Market by Application
5.3 Asia Pacific Neurological Biomarkers Market
5.3.1 Asia Pacific Neurological Biomarkers Market by Type
5.3.1.1 Asia Pacific Proteomic Market by Country
5.3.1.2 Asia Pacific Genomic Market by Country
5.3.1.3 Asia Pacific Metabolomic Market by Country
5.3.1.4 Asia Pacific Others Market by Country
5.3.2 Asia Pacific Neurological Biomarkers Market by Application
5.3.2.1 Asia Pacific Alzheimer's Disease Market by Country
5.3.2.2 Asia Pacific Parkinson’s Disease Market by Country
5.3.2.3 Asia Pacific Multiple Sclerosis Market by Country
5.3.3 Asia Pacific Neurological Biomarkers Market by Country
5.3.3.1 China Neurological Biomarkers Market
5.3.3.1.1 China Neurological Biomarkers Market by Type
5.3.3.1.2 China Neurological Biomarkers Market by Application
5.3.3.2 Japan Neurological Biomarkers Market
5.3.3.2.1 Japan Neurological Biomarkers Market by Type
5.3.3.2.2 Japan Neurological Biomarkers Market by Application
5.3.3.3 India Neurological Biomarkers Market
5.3.3.3.1 India Neurological Biomarkers Market by Type
5.3.3.3.2 India Neurological Biomarkers Market by Application
5.3.3.4 Australia Neurological Biomarkers Market
5.3.3.4.1 Australia Neurological Biomarkers Market by Type
5.3.3.4.2 Australia Neurological Biomarkers Market by Application
5.3.3.5 South Korea Neurological Biomarkers Market
5.3.3.5.1 South Korea Neurological Biomarkers Market by Type
5.3.3.5.2 South Korea Neurological Biomarkers Market by Application
5.3.3.6 Singapore Neurological Biomarkers Market
5.3.3.6.1 Singapore Neurological Biomarkers Market by Type
5.3.3.6.2 Singapore Neurological Biomarkers Market by Application
5.3.3.7 Rest of Asia Pacific Neurological Biomarkers Market
5.3.3.7.1 Rest of Asia Pacific Neurological Biomarkers Market by Type
5.3.3.7.2 Rest of Asia Pacific Neurological Biomarkers Market by Application
5.4 LAMEA Neurological Biomarkers Market
5.4.1 LAMEA Neurological Biomarkers Market by Type
5.4.1.1 LAMEA Proteomic Market by Country
5.4.1.2 LAMEA Genomic Market by Country
5.4.1.3 LAMEA Metabolomic Market by Country
5.4.1.4 LAMEA Others Market by Country
5.4.2 LAMEA Neurological Biomarkers Market by Application
5.4.2.1 LAMEA Alzheimer's Disease Market by Country
5.4.2.2 LAMEA Parkinson’s Disease Market by Country
5.4.2.3 LAMEA Multiple Sclerosis Market by Country
5.4.3 LAMEA Neurological Biomarkers Market by Country
5.4.3.1 Brazil Neurological Biomarkers Market
5.4.3.1.1 Brazil Neurological Biomarkers Market by Type
5.4.3.1.2 Brazil Neurological Biomarkers Market by Application
5.4.3.2 Argentina Neurological Biomarkers Market
5.4.3.2.1 Argentina Neurological Biomarkers Market by Type
5.4.3.2.2 Argentina Neurological Biomarkers Market by Application
5.4.3.3 UAE Neurological Biomarkers Market
5.4.3.3.1 UAE Neurological Biomarkers Market by Type
5.4.3.3.2 UAE Neurological Biomarkers Market by Application
5.4.3.4 Saudi Arabia Neurological Biomarkers Market
5.4.3.4.1 Saudi Arabia Neurological Biomarkers Market by Type
5.4.3.4.2 Saudi Arabia Neurological Biomarkers Market by Application
5.4.3.5 South Africa Neurological Biomarkers Market
5.4.3.5.1 South Africa Neurological Biomarkers Market by Type
5.4.3.5.2 South Africa Neurological Biomarkers Market by Application
5.4.3.6 Nigeria Neurological Biomarkers Market
5.4.3.6.1 Nigeria Neurological Biomarkers Market by Type
5.4.3.6.2 Nigeria Neurological Biomarkers Market by Application
5.4.3.7 Rest of LAMEA Neurological Biomarkers Market
5.4.3.7.1 Rest of LAMEA Neurological Biomarkers Market by Type
5.4.3.7.2 Rest of LAMEA Neurological Biomarkers Market by Application
Chapter 6. Company Profiles
6.1 F. Hoffmann-La Roche Ltd.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Bio-Rad laboratories, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.3 Merck Group
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.4 PerkinElmer, Inc.
6.4.1 Company Overview
6.4.1 Financial Analysis
6.4.2 Segmental and Regional Analysis
6.4.3 Research & Development Expense
6.5 Shimadzu Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.6 Thermo Fisher Scientific, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 BioMérieux S.A.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expenses
6.8 Myriad Genetics, Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental Analysis
6.8.4 Research & Development Expenses
6.9 Quanterix Corporation
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expenses
6.9.5 Recent strategies and developments:
6.9.5.1 Partnerships, Collaborations, and Agreements:
6.10. Neuro-Bio Ltd.
6.10.1 Company Overview
List of Tables
TABLE 1 Global Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 2 Global Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 3 Global Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 4 Global Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 5 Global Proteomic Market by Region, 2018 - 2021, USD Million
TABLE 6 Global Proteomic Market by Region, 2022 - 2028, USD Million
TABLE 7 Global Genomic Market by Region, 2018 - 2021, USD Million
TABLE 8 Global Genomic Market by Region, 2022 - 2028, USD Million
TABLE 9 Global Metabolomic Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Metabolomic Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 14 Global Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 15 Global Alzheimer's Disease Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Alzheimer's Disease Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Parkinson’s Disease Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Parkinson’s Disease Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Multiple Sclerosis Market by Region, 2018 - 2021, USD Million
TABLE 20 Global Multiple Sclerosis Market by Region, 2022 - 2028, USD Million
TABLE 21 Global Neurological Biomarkers Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Neurological Biomarkers Market by Region, 2022 - 2028, USD Million
TABLE 23 North America Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 24 North America Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 25 North America Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 26 North America Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 27 North America Proteomic Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Proteomic Market by Country, 2022 - 2028, USD Million
TABLE 29 North America Genomic Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Genomic Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Metabolomic Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Metabolomic Market by Country, 2022 - 2028, USD Million
TABLE 33 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 36 North America Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 37 North America Alzheimer's Disease Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Alzheimer's Disease Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Parkinson’s Disease Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Parkinson’s Disease Market by Country, 2022 - 2028, USD Million
TABLE 41 North America Multiple Sclerosis Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Multiple Sclerosis Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Neurological Biomarkers Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Neurological Biomarkers Market by Country, 2022 - 2028, USD Million
TABLE 45 US Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 46 US Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 47 US Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 48 US Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 49 US Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 50 US Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 51 Canada Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 52 Canada Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 53 Canada Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 54 Canada Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 55 Canada Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 56 Canada Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 57 Mexico Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 58 Mexico Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 59 Mexico Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 60 Mexico Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 61 Mexico Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 62 Mexico Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 63 Rest of North America Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 64 Rest of North America Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 65 Rest of North America Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 66 Rest of North America Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 67 Rest of North America Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 68 Rest of North America Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 69 Europe Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 70 Europe Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 71 Europe Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 72 Europe Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 73 Europe Proteomic Market by Country, 2018 - 2021, USD Million
TABLE 74 Europe Proteomic Market by Country, 2022 - 2028, USD Million
TABLE 75 Europe Genomic Market by Country, 2018 - 2021, USD Million
TABLE 76 Europe Genomic Market by Country, 2022 - 2028, USD Million
TABLE 77 Europe Metabolomic Market by Country, 2018 - 2021, USD Million
TABLE 78 Europe Metabolomic Market by Country, 2022 - 2028, USD Million
TABLE 79 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 80 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 81 Europe Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 82 Europe Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 83 Europe Alzheimer's Disease Market by Country, 2018 - 2021, USD Million
TABLE 84 Europe Alzheimer's Disease Market by Country, 2022 - 2028, USD Million
TABLE 85 Europe Parkinson’s Disease Market by Country, 2018 - 2021, USD Million
TABLE 86 Europe Parkinson’s Disease Market by Country, 2022 - 2028, USD Million
TABLE 87 Europe Multiple Sclerosis Market by Country, 2018 - 2021, USD Million
TABLE 88 Europe Multiple Sclerosis Market by Country, 2022 - 2028, USD Million
TABLE 89 Europe Neurological Biomarkers Market by Country, 2018 - 2021, USD Million
TABLE 90 Europe Neurological Biomarkers Market by Country, 2022 - 2028, USD Million
TABLE 91 Germany Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 92 Germany Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 93 Germany Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 94 Germany Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 95 Germany Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 96 Germany Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 97 UK Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 98 UK Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 99 UK Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 100 UK Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 101 UK Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 102 UK Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 103 France Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 104 France Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 105 France Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 106 France Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 107 France Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 108 France Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 109 Russia Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 110 Russia Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 111 Russia Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 112 Russia Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 113 Russia Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 114 Russia Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 115 Spain Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 116 Spain Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 117 Spain Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 118 Spain Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 119 Spain Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 120 Spain Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 121 Italy Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 122 Italy Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 123 Italy Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 124 Italy Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 125 Italy Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 126 Italy Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 127 Rest of Europe Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 128 Rest of Europe Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 129 Rest of Europe Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 130 Rest of Europe Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 131 Rest of Europe Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 132 Rest of Europe Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 133 Asia Pacific Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 134 Asia Pacific Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 135 Asia Pacific Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 136 Asia Pacific Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 137 Asia Pacific Proteomic Market by Country, 2018 - 2021, USD Million
TABLE 138 Asia Pacific Proteomic Market by Country, 2022 - 2028, USD Million
TABLE 139 Asia Pacific Genomic Market by Country, 2018 - 2021, USD Million
TABLE 140 Asia Pacific Genomic Market by Country, 2022 - 2028, USD Million
TABLE 141 Asia Pacific Metabolomic Market by Country, 2018 - 2021, USD Million
TABLE 142 Asia Pacific Metabolomic Market by Country, 2022 - 2028, USD Million
TABLE 143 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 144 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 145 Asia Pacific Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 146 Asia Pacific Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 147 Asia Pacific Alzheimer's Disease Market by Country, 2018 - 2021, USD Million
TABLE 148 Asia Pacific Alzheimer's Disease Market by Country, 2022 - 2028, USD Million
TABLE 149 Asia Pacific Parkinson’s Disease Market by Country, 2018 - 2021, USD Million
TABLE 150 Asia Pacific Parkinson’s Disease Market by Country, 2022 - 2028, USD Million
TABLE 151 Asia Pacific Multiple Sclerosis Market by Country, 2018 - 2021, USD Million
TABLE 152 Asia Pacific Multiple Sclerosis Market by Country, 2022 - 2028, USD Million
TABLE 153 Asia Pacific Neurological Biomarkers Market by Country, 2018 - 2021, USD Million
TABLE 154 Asia Pacific Neurological Biomarkers Market by Country, 2022 - 2028, USD Million
TABLE 155 China Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 156 China Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 157 China Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 158 China Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 159 China Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 160 China Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 161 Japan Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 162 Japan Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 163 Japan Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 164 Japan Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 165 Japan Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 166 Japan Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 167 India Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 168 India Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 169 India Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 170 India Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 171 India Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 172 India Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 173 Australia Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 174 Australia Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 175 Australia Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 176 Australia Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 177 Australia Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 178 Australia Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 179 South Korea Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 180 South Korea Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 181 South Korea Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 182 South Korea Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 183 South Korea Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 184 South Korea Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 185 Singapore Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 186 Singapore Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 187 Singapore Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 188 Singapore Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 189 Singapore Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 190 Singapore Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 191 Rest of Asia Pacific Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 192 Rest of Asia Pacific Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 193 Rest of Asia Pacific Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 194 Rest of Asia Pacific Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 195 Rest of Asia Pacific Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 196 Rest of Asia Pacific Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 197 LAMEA Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 198 LAMEA Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 199 LAMEA Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 200 LAMEA Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 201 LAMEA Proteomic Market by Country, 2018 - 2021, USD Million
TABLE 202 LAMEA Proteomic Market by Country, 2022 - 2028, USD Million
TABLE 203 LAMEA Genomic Market by Country, 2018 - 2021, USD Million
TABLE 204 LAMEA Genomic Market by Country, 2022 - 2028, USD Million
TABLE 205 LAMEA Metabolomic Market by Country, 2018 - 2021, USD Million
TABLE 206 LAMEA Metabolomic Market by Country, 2022 - 2028, USD Million
TABLE 207 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 208 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 209 LAMEA Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 210 LAMEA Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 211 LAMEA Alzheimer's Disease Market by Country, 2018 - 2021, USD Million
TABLE 212 LAMEA Alzheimer's Disease Market by Country, 2022 - 2028, USD Million
TABLE 213 LAMEA Parkinson’s Disease Market by Country, 2018 - 2021, USD Million
TABLE 214 LAMEA Parkinson’s Disease Market by Country, 2022 - 2028, USD Million
TABLE 215 LAMEA Multiple Sclerosis Market by Country, 2018 - 2021, USD Million
TABLE 216 LAMEA Multiple Sclerosis Market by Country, 2022 - 2028, USD Million
TABLE 217 LAMEA Neurological Biomarkers Market by Country, 2018 - 2021, USD Million
TABLE 218 LAMEA Neurological Biomarkers Market by Country, 2022 - 2028, USD Million
TABLE 219 Brazil Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 220 Brazil Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 221 Brazil Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 222 Brazil Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 223 Brazil Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 224 Brazil Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 225 Argentina Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 226 Argentina Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 227 Argentina Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 228 Argentina Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 229 Argentina Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 230 Argentina Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 231 UAE Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 232 UAE Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 233 UAE Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 234 UAE Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 235 UAE Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 236 UAE Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 237 Saudi Arabia Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 238 Saudi Arabia Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 239 Saudi Arabia Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 240 Saudi Arabia Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 241 Saudi Arabia Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 242 Saudi Arabia Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 243 South Africa Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 244 South Africa Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 245 South Africa Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 246 South Africa Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 247 South Africa Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 248 South Africa Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 249 Nigeria Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 250 Nigeria Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 251 Nigeria Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 252 Nigeria Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 253 Nigeria Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 254 Nigeria Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 255 Rest of LAMEA Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 256 Rest of LAMEA Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 257 Rest of LAMEA Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 258 Rest of LAMEA Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 259 Rest of LAMEA Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 260 Rest of LAMEA Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 261 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 262 Key Information – Bio-Rad Laboratories, Inc.
TABLE 263 key Information – Merck GrouP
TABLE 264 key Information – PerkinElmer, Inc.
TABLE 265 Key Information – Shimadzu Corporation
TABLE 266 Key Information – Thermo Fisher Scientific, Inc.
TABLE 267 Key information – BioMérieux S.A.
TABLE 268 Key Information – Myriad Genetics, Inc.
TABLE 269 Key Information – QUANTERIX CORPORATION
TABLE 270 Key Information – Neuro-Bio Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 Global Neurological Biomarkers Market Share by Type, 2021
FIG 3 Global Neurological Biomarkers Market Share by Type, 2028
FIG 4 Global Neurological Biomarkers Market by Type, 2018 - 2028, USD Million
FIG 5 Global Neurological Biomarkers Market by Application, 2021
FIG 6 Global Neurological Biomarkers Market by Application, 2028
FIG 7 Global Neurological Biomarkers Market by Application, 2018 - 2028, USD Million
FIG 8 Global Neurological Biomarkers Market Share by Region, 2021
FIG 9 Global Neurological Biomarkers Market Share by Region, 2028
FIG 10 Global Neurological Biomarkers Market by Region, 2018 - 2028, USD Million
TABLE 2 Global Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 3 Global Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 4 Global Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 5 Global Proteomic Market by Region, 2018 - 2021, USD Million
TABLE 6 Global Proteomic Market by Region, 2022 - 2028, USD Million
TABLE 7 Global Genomic Market by Region, 2018 - 2021, USD Million
TABLE 8 Global Genomic Market by Region, 2022 - 2028, USD Million
TABLE 9 Global Metabolomic Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Metabolomic Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 14 Global Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 15 Global Alzheimer's Disease Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Alzheimer's Disease Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Parkinson’s Disease Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Parkinson’s Disease Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Multiple Sclerosis Market by Region, 2018 - 2021, USD Million
TABLE 20 Global Multiple Sclerosis Market by Region, 2022 - 2028, USD Million
TABLE 21 Global Neurological Biomarkers Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Neurological Biomarkers Market by Region, 2022 - 2028, USD Million
TABLE 23 North America Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 24 North America Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 25 North America Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 26 North America Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 27 North America Proteomic Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Proteomic Market by Country, 2022 - 2028, USD Million
TABLE 29 North America Genomic Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Genomic Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Metabolomic Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Metabolomic Market by Country, 2022 - 2028, USD Million
TABLE 33 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 36 North America Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 37 North America Alzheimer's Disease Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Alzheimer's Disease Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Parkinson’s Disease Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Parkinson’s Disease Market by Country, 2022 - 2028, USD Million
TABLE 41 North America Multiple Sclerosis Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Multiple Sclerosis Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Neurological Biomarkers Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Neurological Biomarkers Market by Country, 2022 - 2028, USD Million
TABLE 45 US Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 46 US Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 47 US Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 48 US Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 49 US Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 50 US Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 51 Canada Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 52 Canada Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 53 Canada Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 54 Canada Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 55 Canada Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 56 Canada Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 57 Mexico Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 58 Mexico Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 59 Mexico Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 60 Mexico Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 61 Mexico Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 62 Mexico Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 63 Rest of North America Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 64 Rest of North America Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 65 Rest of North America Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 66 Rest of North America Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 67 Rest of North America Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 68 Rest of North America Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 69 Europe Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 70 Europe Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 71 Europe Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 72 Europe Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 73 Europe Proteomic Market by Country, 2018 - 2021, USD Million
TABLE 74 Europe Proteomic Market by Country, 2022 - 2028, USD Million
TABLE 75 Europe Genomic Market by Country, 2018 - 2021, USD Million
TABLE 76 Europe Genomic Market by Country, 2022 - 2028, USD Million
TABLE 77 Europe Metabolomic Market by Country, 2018 - 2021, USD Million
TABLE 78 Europe Metabolomic Market by Country, 2022 - 2028, USD Million
TABLE 79 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 80 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 81 Europe Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 82 Europe Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 83 Europe Alzheimer's Disease Market by Country, 2018 - 2021, USD Million
TABLE 84 Europe Alzheimer's Disease Market by Country, 2022 - 2028, USD Million
TABLE 85 Europe Parkinson’s Disease Market by Country, 2018 - 2021, USD Million
TABLE 86 Europe Parkinson’s Disease Market by Country, 2022 - 2028, USD Million
TABLE 87 Europe Multiple Sclerosis Market by Country, 2018 - 2021, USD Million
TABLE 88 Europe Multiple Sclerosis Market by Country, 2022 - 2028, USD Million
TABLE 89 Europe Neurological Biomarkers Market by Country, 2018 - 2021, USD Million
TABLE 90 Europe Neurological Biomarkers Market by Country, 2022 - 2028, USD Million
TABLE 91 Germany Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 92 Germany Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 93 Germany Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 94 Germany Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 95 Germany Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 96 Germany Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 97 UK Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 98 UK Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 99 UK Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 100 UK Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 101 UK Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 102 UK Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 103 France Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 104 France Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 105 France Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 106 France Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 107 France Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 108 France Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 109 Russia Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 110 Russia Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 111 Russia Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 112 Russia Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 113 Russia Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 114 Russia Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 115 Spain Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 116 Spain Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 117 Spain Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 118 Spain Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 119 Spain Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 120 Spain Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 121 Italy Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 122 Italy Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 123 Italy Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 124 Italy Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 125 Italy Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 126 Italy Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 127 Rest of Europe Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 128 Rest of Europe Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 129 Rest of Europe Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 130 Rest of Europe Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 131 Rest of Europe Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 132 Rest of Europe Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 133 Asia Pacific Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 134 Asia Pacific Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 135 Asia Pacific Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 136 Asia Pacific Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 137 Asia Pacific Proteomic Market by Country, 2018 - 2021, USD Million
TABLE 138 Asia Pacific Proteomic Market by Country, 2022 - 2028, USD Million
TABLE 139 Asia Pacific Genomic Market by Country, 2018 - 2021, USD Million
TABLE 140 Asia Pacific Genomic Market by Country, 2022 - 2028, USD Million
TABLE 141 Asia Pacific Metabolomic Market by Country, 2018 - 2021, USD Million
TABLE 142 Asia Pacific Metabolomic Market by Country, 2022 - 2028, USD Million
TABLE 143 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 144 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 145 Asia Pacific Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 146 Asia Pacific Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 147 Asia Pacific Alzheimer's Disease Market by Country, 2018 - 2021, USD Million
TABLE 148 Asia Pacific Alzheimer's Disease Market by Country, 2022 - 2028, USD Million
TABLE 149 Asia Pacific Parkinson’s Disease Market by Country, 2018 - 2021, USD Million
TABLE 150 Asia Pacific Parkinson’s Disease Market by Country, 2022 - 2028, USD Million
TABLE 151 Asia Pacific Multiple Sclerosis Market by Country, 2018 - 2021, USD Million
TABLE 152 Asia Pacific Multiple Sclerosis Market by Country, 2022 - 2028, USD Million
TABLE 153 Asia Pacific Neurological Biomarkers Market by Country, 2018 - 2021, USD Million
TABLE 154 Asia Pacific Neurological Biomarkers Market by Country, 2022 - 2028, USD Million
TABLE 155 China Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 156 China Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 157 China Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 158 China Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 159 China Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 160 China Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 161 Japan Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 162 Japan Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 163 Japan Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 164 Japan Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 165 Japan Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 166 Japan Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 167 India Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 168 India Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 169 India Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 170 India Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 171 India Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 172 India Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 173 Australia Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 174 Australia Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 175 Australia Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 176 Australia Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 177 Australia Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 178 Australia Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 179 South Korea Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 180 South Korea Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 181 South Korea Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 182 South Korea Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 183 South Korea Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 184 South Korea Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 185 Singapore Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 186 Singapore Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 187 Singapore Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 188 Singapore Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 189 Singapore Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 190 Singapore Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 191 Rest of Asia Pacific Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 192 Rest of Asia Pacific Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 193 Rest of Asia Pacific Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 194 Rest of Asia Pacific Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 195 Rest of Asia Pacific Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 196 Rest of Asia Pacific Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 197 LAMEA Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 198 LAMEA Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 199 LAMEA Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 200 LAMEA Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 201 LAMEA Proteomic Market by Country, 2018 - 2021, USD Million
TABLE 202 LAMEA Proteomic Market by Country, 2022 - 2028, USD Million
TABLE 203 LAMEA Genomic Market by Country, 2018 - 2021, USD Million
TABLE 204 LAMEA Genomic Market by Country, 2022 - 2028, USD Million
TABLE 205 LAMEA Metabolomic Market by Country, 2018 - 2021, USD Million
TABLE 206 LAMEA Metabolomic Market by Country, 2022 - 2028, USD Million
TABLE 207 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 208 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 209 LAMEA Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 210 LAMEA Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 211 LAMEA Alzheimer's Disease Market by Country, 2018 - 2021, USD Million
TABLE 212 LAMEA Alzheimer's Disease Market by Country, 2022 - 2028, USD Million
TABLE 213 LAMEA Parkinson’s Disease Market by Country, 2018 - 2021, USD Million
TABLE 214 LAMEA Parkinson’s Disease Market by Country, 2022 - 2028, USD Million
TABLE 215 LAMEA Multiple Sclerosis Market by Country, 2018 - 2021, USD Million
TABLE 216 LAMEA Multiple Sclerosis Market by Country, 2022 - 2028, USD Million
TABLE 217 LAMEA Neurological Biomarkers Market by Country, 2018 - 2021, USD Million
TABLE 218 LAMEA Neurological Biomarkers Market by Country, 2022 - 2028, USD Million
TABLE 219 Brazil Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 220 Brazil Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 221 Brazil Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 222 Brazil Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 223 Brazil Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 224 Brazil Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 225 Argentina Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 226 Argentina Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 227 Argentina Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 228 Argentina Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 229 Argentina Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 230 Argentina Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 231 UAE Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 232 UAE Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 233 UAE Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 234 UAE Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 235 UAE Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 236 UAE Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 237 Saudi Arabia Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 238 Saudi Arabia Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 239 Saudi Arabia Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 240 Saudi Arabia Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 241 Saudi Arabia Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 242 Saudi Arabia Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 243 South Africa Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 244 South Africa Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 245 South Africa Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 246 South Africa Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 247 South Africa Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 248 South Africa Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 249 Nigeria Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 250 Nigeria Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 251 Nigeria Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 252 Nigeria Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 253 Nigeria Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 254 Nigeria Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 255 Rest of LAMEA Neurological Biomarkers Market, 2018 - 2021, USD Million
TABLE 256 Rest of LAMEA Neurological Biomarkers Market, 2022 - 2028, USD Million
TABLE 257 Rest of LAMEA Neurological Biomarkers Market by Type, 2018 - 2021, USD Million
TABLE 258 Rest of LAMEA Neurological Biomarkers Market by Type, 2022 - 2028, USD Million
TABLE 259 Rest of LAMEA Neurological Biomarkers Market by Application, 2018 - 2021, USD Million
TABLE 260 Rest of LAMEA Neurological Biomarkers Market by Application, 2022 - 2028, USD Million
TABLE 261 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 262 Key Information – Bio-Rad Laboratories, Inc.
TABLE 263 key Information – Merck GrouP
TABLE 264 key Information – PerkinElmer, Inc.
TABLE 265 Key Information – Shimadzu Corporation
TABLE 266 Key Information – Thermo Fisher Scientific, Inc.
TABLE 267 Key information – BioMérieux S.A.
TABLE 268 Key Information – Myriad Genetics, Inc.
TABLE 269 Key Information – QUANTERIX CORPORATION
TABLE 270 Key Information – Neuro-Bio Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 Global Neurological Biomarkers Market Share by Type, 2021
FIG 3 Global Neurological Biomarkers Market Share by Type, 2028
FIG 4 Global Neurological Biomarkers Market by Type, 2018 - 2028, USD Million
FIG 5 Global Neurological Biomarkers Market by Application, 2021
FIG 6 Global Neurological Biomarkers Market by Application, 2028
FIG 7 Global Neurological Biomarkers Market by Application, 2018 - 2028, USD Million
FIG 8 Global Neurological Biomarkers Market Share by Region, 2021
FIG 9 Global Neurological Biomarkers Market Share by Region, 2028
FIG 10 Global Neurological Biomarkers Market by Region, 2018 - 2028, USD Million